Acacia Pharma Group Plc
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Partnering
  • Media
    • Press Releases
    • Events
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholding Structure
    • Share Information
    • Share Price and Charts
    • Financial Reports and Presentations
    • Shareholder Meetings
    • Financial Calendar
    • Analysts
    • Corporate Governance
    • California Compliance statement
    • Comprehensive Compliance Plan
    • Warning for Shareholders
    • Subscribe for Updates
    • Offering Documents
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Partnering
  • Media
    • Press Releases
    • Events
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholding Structure
    • Share Information
    • Share Price and Charts
    • Financial Reports and Presentations
    • Shareholder Meetings
    • Financial Calendar
    • Analysts
    • Corporate Governance
    • California Compliance statement
    • Comprehensive Compliance Plan
    • Warning for Shareholders
    • Subscribe for Updates
    • Offering Documents
  • Contact

Transforming medicine

Advancing care

Home > News > Archive: 2012

Press Releases

01 October 2012

Acacia Pharma Announces Positive Results From Phase 2a Nausea & Vomiting Study In Cancer Patients

12 May 2012

Acacia Pharma Announces Excellent Phase 2 Results For APD421 In PONV

04 January 2012

Phase 2 Study Initiated With APD421 In Post-Operative Nausea & Vomiting (PONV)
  • 2022 (5)
  • 2021 (16)
  • 2020 (18)
  • 2019 (13)
  • 2018 (14)
  • 2017 (1)
  • 2016 (3)
  • 2015 (4)
  • 2014 (1)
  • 2013 (4)
  • 2012 (3)
  • 2011 (7)
  • 2010 (1)
  • 2009 (5)
  • 2008 (3)
Acacia Pharma Group Plc
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map

© 2023 Acacia Pharma Group Plc

(Registered in England and Wales No: 09759376)
Registered office address: The Officers’ Mess, Royston Road, Duxford, Cambridge CB22 4QH, UK

Acacia Pharma Limited (Registered in England and Wales No: 05934843) and Acacia Pharma Inc (Incorporated under the laws of Delaware, No: 5799660) are members of the Acacia Pharma Group

Website by Instinctif Partners

By continuing to use acaciapharma.com you will be agreeing to the website Terms & Conditions, the Privacy Policy, and the use of Cookies.